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          Earlier diabetes mellitus (DM) was thought to be a disease of carbohydrate 
metabolism. Looking at the effects of insulin deficiency on carbohydrate and lipid 
metabolism, diabetes mellitus is now being called more a disease of lipid metabolism 
than carbohydrate metabolism. A cross-sectional study was conducted during March 
2005 to March 2006 to study the low-density lipoproteins (LDL) levels in diabetes mellitus 
and its relation to glycaemic control. LDL levels were estimated. Comparison of lipid 
levels were made between  group of diabetic patients with glycated hemoglobin less than 
8.0% and a group of diabetic patients with glycated hemoglobin more than 8.0%  and the 
controls. The lipid fractions i.e. total cholesterol (TC), triglycerides (TG), and low-density 
lipoprotein (LDL) levels were higher in the poorly controlled diabetes patients as 
compared to well controlled diabetic patients and nondiabetic patients. Increased levels 
of low-density lipoprotein may be a contributory factor to the high risk of atherosclerosis 
induced coronary artery disease observed in diabetes mellitus patients. Reduction of 
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blood glucose levels is likely to reduce low density lipoprotein levels and the risk of 
complication, with the lowest risk being in those with glycosylated hemoglobin values in 
the normal range ie. Less than 8.0% 
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INTRODUCTION 
 
Diabetes mellitus (D.M) is the commonest 
endocrine disease affecting mankind. The 
incidence of disease is on a rise not only in 
developed countries but also in developing 
countries. Diabetes mellitus is a metabolic 
disorder characterized by elevated fasting 
and postprandial blood glucose level and 
variety of multisystem complications, 
mainly in the blood vessels of eye, kidney, 
nervous system and integument. The heavy 
toll of death each year is due to its 
complications, which is usually common in 
age group 40-60 years affecting both sexes 
equally. The complications are more 
prevalent among the people of lower 
socioeconomic status because of negligence, 
illiteracy, poverty etc. 
 
Coronary artery disease (CAD) especially 
Myocardial Infarction (MI) has reached 
enormous proportions striking more and 
more young subjects especially in patients 
with diabetes mellitus. It will result in 
greatest epidemic which mankind has ever 
faced in coming years unless we are able to 
reverse the trends by concentrated results 
into its cause and its prevention. 
 
Among the very many risk factors identified 
for acceleration of the atherosclerotic 
process and thus predisposition to ischemic 
heart disease are hyperlipidemia and hyper 
lipoproteinemias. Cholesterol was 
incriminated as an etiologic factor for 
atherosclerosis long back when cholesterol 
was found in the atheromatus plaques. 
Various studies around the world have well 
established that low density lipoprotein, and 
very low density lipoprotein (VLDL) are 
atherogenic whereas high density lipoprotein 
(HDL) is a protective factor against 
coronary atherosclerosis and hence against 
MI.The present study was designed to 
estimate low-density lipoproteins (LDL) 
levels in diabetes mellitus and its relation to 
glycaemic control.  
 
Aims and objectives of the study: 
1. To study the levels of low-density 
lipoprotein cholesterol in type-2 diabetes 
mellitus. 
2. To study the relation of low-density 
lipoprotein cholesterol to glycaemic control, 
as estimated by glycosylated hemoglobin 
concentration. 
 
 
METHODS 
 
The study group comprise of 50 subjects 
above 30 years of age having Type-2 
diabetes mellitus. The control group 
comprise of 50 healthy subjects above 30 
years of age. Cases are collected from 
outpatients and inpatients visiting 
R.L.Jalappa hospital and S.N.R. hospital 
attached to Sri Devraj Urs Medical College, 
Tamaka, Kolar, Karnataka, India and 50 age 
matched controls. History was taken in 
detail with informed consent and general 
physical examination was done after the 
clearance from ethical committee. Subjects 
with history of hypertension, lung or cardiac 
disease, smoking and alcoholism, on any 
drug affecting lipid levels of plasma are 
excluded from the study. Blood Samples are 
collected between 7 AM to 8 AM after 
overnight fasting. Lipid levels are estimated 
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by standard method. Low density 
lipoproteins are calculated by Friedewald’s 
formula (1972): 
Low Density Lipoprotein= Total 
Cholesterol- High Density Lipoprotein -
Triglycerides /5 
 
Glycosylated hemoglobin (HbA1c levels) 
was estimated by using Glycohemoglobin 
Reagent set, provided by Pointe Scientific 
Inc. Study group was again divided into two 
groups: 
Group A. Poor glycemic control- HbA1c 
levels >8.0% 
Group B. good glycemic control- HbA1c 
levels <8.0%  
                       
                                              
RESULTS 
 
One hundred male subjects were selected as 
per the criteria laid down in the methods and 
materials sections for the present study 
.They were grouped as study group (Group 
A and Group B) and controls (Group 
C).Lipid levels and glycosylated 
hemoglobin levels were estimated in all 
groups. The data collected have been 
statistically analyzed and discussed. Lipid 
levels and glycosylated hemoglobin levels 
were compared between the three groups 
and the results discussed. The data was 
suitably arranged into suitable tables from 
the master chart for discussion under 
different headings. Analysis was performed 
using SPSS 8.0 statistical package for 
windows .Continuous variables are 
expressed as the mean + standard deviation 
and qualitative data as percentages. 
Comparison of patient’s features was 
performed using Student’s t test for unpaired 
data. Pearson correlation coefficient test (r 
value) was carried out to known the 
correlation of HbA1C and LDL.Chi-sqaure 
test was carried out to evaluate the 
significance of CAD in different groups.   
The mean difference is significant at P<0.05 
level. Conclusion was drawn based on 
outcome of this statistical treatment. 
 
Table 1 shows the distribution of the 
subjects according to the age. The youngest 
subject in the study group is aged 32 years 
and the oldest aged 68 years. The youngest 
subject in the control group is aged 31 years 
and the oldest aged 69 years. The mean age 
of the study group was 48.56 years and 
control group was 48.96 years. The 
maximum incidence of the coronary artery 
disease was found in the age group of 40-50 
years. 
Study group is further subdivided into  
1. Poorly controlled DM (Group A):HbA1C 
>8% 
2. Well controlled DM (Group B): HbA1C 
<8% 
 
Table1: Distribution of subjects depending on age  
Age group 
(Years) 
Study group  Control group
30‐39  8  10 
40‐49  21  20 
50‐59  12  10 
>60  9  10 
Total 50  50 
 
Table 2 shows distribution of study group 
depending on age. The youngest subject in 
the Group A is aged 32 years and the oldest 
aged 64 years. The youngest subject in the 
Group B is aged 35 years and the oldest 
aged 68 years. The mean age of the Group A 
was 48.32 years and Group B was 48.80 
years. 
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Table2: Distribution of study group depending on 
age 
Age group 
(Years) 
Poorly 
controlled 
DM 
Well 
controlled 
DM 
30‐39  5 3 
40‐49  10 11 
50‐59  5 7 
>60  5 4 
Total  25 25 
 
Table 3 shows HbA1C levels and LDL 
levels in different groups. HbA1C is 
significantly higher in the poorly controlled 
diabetes mellitus patients. It shows that as 
the glycaemic level increases, the LDL level 
also increases.LDL levels are significantly 
higher in poorly controlled diabetes patients 
whose HbA1C levels were elevated. There 
is a high correlation between HbA1C and 
LDL levels (Pearson correlation coefficient) 
in all the three groups (P<0.01). 
Table 4 shows the mean values and standard 
deviations of the various lipid fractions in 
Group-A (poorly controlled diabetics) in 
comparison to that of Group-B (Well 
controlled diabetics) and Group C (Control) 
as well as the similar comparison between 
Groups B and C. It can be seen that mean 
value of all lipid fractions TC, HDL-C, 
LDL, TC/HDL, LDL/HDL are higher in the 
poorly controlled diabetics when compared 
to Group-B and is statistically significant. 
The TG was higher in Group-B than in 
poorly-controlled diabetics but is not 
statistically significant. It can also be seen 
that mean value of all lipid fractions TC, 
TG, LDL, TC/HDL, LDL/HDL are higher in 
the poorly controlled diabetics when 
compared to controls and is statistically 
significant. The HDL-Ch was higher in 
controls than in poorly controlled diabetics 
and is a safety factor. According to Table 3, 
the mean value of Triglycerides and 
TC/HDL are higher in the well controlled 
diabetics when compared to controls and is 
statistically significant. The TC, LDL-Ch 
and LDL/HDL did not show much change 
and is not statistically significant. The HDL-
Ch was higher in controls than in well-
controlled diabetics and is a safety factor.
 
Table3: HbA1C and LDL levels in different groups 
Subjects HbA1C LEVELS  LDL LEVELS  SIGNIFICANCE 
Group A  9.61 + 1.58  156 + 25.09  r =+0.9966, P<0.0001 
Group B  5.61 + 1.33  91.28 + 21.59  r =+0.9999, P<0.0001 
Group C  5.62 + 1.65  90.54 + 28.77  r =+0.9709, P<0.01 
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TABLE 4: Comparison of lipid levels in different groups 
Subjects NO.  of 
cases 
TC TG HDL‐C LDL‐C TC/HDL  LDL/HDL 
Group A  25 224.88 
+ 29.75 
179.40 
+ 59.90 
36.20 
+ 6.14 
156.00 
+ 25.09 
6.36 
+ 1.47 
4.23 
+  0.84 
Group B  25 171.16 
+ 17.58 
213.04 
+ 111.19 
34.68 
+ 4.83 
91.28 
+ 21.59 
5.03 
+ 0.91 
2.65 
+ 0.84 
Group C  50 162.30 
+ 33.67 
147.44 
+ 43.64 
41.46 
+ 8.18 
90.54 
+ 28.77 
4.04 
+ 1.03 
2.33 
+ 0.81 
 
A‐B 
t  ‐  7.77 1.33 0.97 9.77 2.33 6.58 
P  ‐ <0.001  >0.05 >0.05 <0.001  <0.05 <0.001 
Sig.  ‐ VHSS
2 NSS
3  NSS  VHSS     SS
1 VHSS 
 
A‐C 
t  ‐  8.23 2.37 3.11 10.13  7.09 9.41 
P  ‐ <0.001  <0.05 <0.01 <0.001  <0.001  <0.001 
Sig.  ‐ VHSS SS  HSS  VHSS VHSS VHSS 
 
B‐C 
t  ‐  0.15 2.84 4.49 0.13 4.25 1.58 
P  ‐  >0.05 <0.01 <0.001  >0.05 <0.001  >0.05 
Sig.  ‐  NSS  HSS  VHSS NSS  VHSS NSS 
1: Statistically Significant (SS)  
2: Very Highly Statistically Significant (VHSS) 
3: Not Statistically Significant (NSS) 
 
 
 
DISCUSSION 
 
Diabetes mellitus acts as a major risk factor 
for atherosclerosis either alone or in 
combination with other major risk factors 
such as diet, smoking, body weight etc.It has 
been found that patients with type-2 diabetes 
mellitus suffer from dyslipidemia which in 
turn leads to various vascular complications. 
In this study, patients with type-2 diabetes 
mellitus were grouped as poorly controlled 
and well controlled groups depending on 
their glycosylated hemoglobin levels and 
their lipid levels are compared with that of 
normal subjects. The results are analyzed 
and discussed below. 
 
The present study has shown that the lipid 
fraction, TC, TG, LDL, VLDL, TC/HDL 
and LDL/HDL ratios are higher in DM 
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group than healthy controls as seen in the 
tables 4, 5 and 6 which are in accordance 
with most of the previous reports by various 
workers. In the present study except TG and 
VLDL, all other changes are statistically 
significant (P<0.01). The HDL was also low 
in DM group and was statistically significant 
(P<0.01). This goes in favor of many other 
studies. Formation of glycated hemoglobin 
is essentially irreversible, and the blood 
levels depend on both the life span of the red 
blood cell (average 120 days) and the blood 
glucose concentration. Because the rate of 
formation of glycated hemoglobin is directly 
proportional to the concentration of glucose 
in the blood .The glycated hemoglobin 
concentration represents the integrated 
values for glucose over the preceding 6 to 8 
weeks. This provides an additional criterion 
for assessing glucose controls because 
glycated hemoglobin values are free from 
day to day glucose fluctuations and are 
unaffected by exercise or recent food 
ingestion(1). The glycated hemoglobin 
(HbA1C) test measures the percentage of 
that glycated hemoglobin, offering a 
snapshot of the average blood sugar control 
for the past few months.  
 
Relationship between IDL and glycaemic 
control:   
The mean and standard deviation of HbA1C   
in the three groups, GroupA, Group B, and 
Group C are 9.61+1.58, 5.61+1.33 and 
5.62+1.65 respectively and the mean and 
standard deviation of LDL levels in the three 
groups, GroupA, Group B, and Group C are 
156+25.09, 91.28+21.59 and 90.54+28.77 
respectively.LDL levels are significantly 
higher in the poorly controlled diabetes 
patients whose glycosylated hemoglobin 
levels are elevated. There is a high 
correlation between the HbA1C   levels and 
LDL levels in the poorly controlled group 
(R =0.997, P<0.01).  
 
The finding of the present study is in 
conformity with the earlier studies done by 
Ramirez LC, Pacheco CA, Lackner C, et 
al.and Wagner Am, Jorba O, Rigla M et al. 
Wagner Am, Jorba O, Rigla M et al studied 
the effect of improving glycemic control on 
low-density lipoprotein particle size in 33 
type-2 diabetes mellitus patients in a 
longitudinal intervention study. It was found 
that with glycaemia control a significant 
reduction in the LDL- cholesterol and ApoB 
and an increase in HDL- cholesterol and 
Apo AI were seen (2). Ramirez LC, Pacheco 
CA, Lackner C, et al. studied 60 diabetic 
patients with HbA1c with levels of 8.0% or 
higher had higher (25mg/dl) median levels 
of lipoprotein (a) when compared with either 
93 normal controls (8.8 mg/dl) Or 33 
diabetic patients with less than 8.0% 
(7.5mg/dl) (p=0.008 and p=0.012 
respectively). He concluded that Lipoprotein 
(a) levels are elevated in poorly controlled 
diabetic patients (3). 
 
The prevalence of dyslipidaemia in children 
with insulin dependent diabetes mellitus 
(IDDM) and its relation to glycaemic control 
was studied in a group of 51 diabetic 
children and a control population of 132 
schoolchildren. Serum total cholesterol, 
triglycerides, and apolipoprotein (apo) B 
concentrations increased with worsening 
control, while serum high density 
lipoprotein cholesterol and apoA-I 
concentrations were unaltered (4). 
 
Another study showed Triglycerides, LDL-
cholesterol, and total serum lipids levels of 
poorly diabetic children (HbA1c > 8 %), 
were respectively higher (p<0.01), (p<0.05) 
and (p<0.01) than those of the control group. 
However, HDL-cholesterol level was 
significantly lower (p<0.01) in poorly 
diabetic children than in control group. They 
concluded increased levels of LDL 
cholesterol and triglycerides levels showed 
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that especially poorly controlled diabetes 
mellitus children present a high risk of 
atherosclerosis and vascular complications 
of diabetes mellitus. They showed a 
significant relationship between the lipid 
profile and the poor glycaemic control in 
diabetic children (5). 
 
Glycosylation of low density lipoproteins 
obtained from 16 patients with Type 1 
(insulin-dependent) diabetes and from 16 
age-, sex-, and race-matched controls, was 
determined. Glycosylation of low density 
lipoproteins in the diabetic patients was 
significantly higher (p < 0.001) than in the 
control subjects, and was significantly 
correlated with haemoglobin A1c, (p < 
0.01), glycosylation of plasma proteins, (p < 
0.001), and mean home blood glucose, (p < 
0.01). This study confirms that, in diabetic 
patients, increased glycosylation of low 
density lipoprotein occurs to an extent which 
correlates closely with other commonly used 
indices of glycaemic control(6). 
 
Another study showed hyperglycaemia has a 
potent but reversible effect on LDL 
oxidation and that age may independently 
enhance LDL susceptibility to oxidation. 
These pathophysiological effects may play 
an important role in determining vascular 
complications and atherogenesis in poorly 
controlled type 1 diabetic patients (7). 
Another study concluded that both 
glycaemic control and familial factors may 
be important determinants of lipid levels in 
young people with diabetes. Both may 
contribute to the subsequent risk of 
cardiovascular disease and possibly the 
development of incipient diabetic 
nephropathy (8). 
 
In this study, they evaluated whether the 
level of glycemic control affected the 
oxidizability of LDL in patients with type2 
diabetes mellitus (DM). In incubation with 
40.MU.M FeSO4, the thiobarbituric acid-
reactive substances (TBARS) level in type2 
DM patients was significantly higher than 
that of non-DM subjects. TBARS levels of 
the poorly-controlled group were 
significantly higher than those of the well-
controlled group when incubated with 10 
and 40.MU.M FeSO4. The lipid profile and 
.ALPHA.-tocopherol content of LDL did not 
differ significantly in each group. These 
results suggest that sustained hyperglycemia 
leads to LDL glycation and contributes to 
acceleration of LDL oxidation (9). 
 
Many others studied the effect of insulin and 
sulfonylurea therapy on low density 
lipoprotein subfractions, effect of obesity, 
distribution of low density lipoprotein (10-
16). Wei M, Gaskill SP, Haffner SM, Stern 
MP studied the effects of diabetes and level 
of glycaemia on all-cause and 
cardiovascular mortality (17). The basis of 
this finding is whenever the glycaemic level 
increases as in the diabetes mellitus patients; 
the LDL will get glycated.This chemically 
modified glycated LDL causes inhibition of 
the ability of LDL to interact with the LDL 
receptors. This in turn inhibits the ability of 
the LDL to be metabolized by the LDL 
receptor pathway. Thus plasma LDL levels 
are high and atherosclerosis occurs early in 
life (18). 
 
Another mechanism shows chronic 
hyperglycemia leads to nonenzymatic 
glycation of LDL and collagen fibers 
leading to formation of Schiff base which in 
turn forms amadori products. This causes 
tissue damage by reactivity and protein cross 
linking. The glycated LDL also binds with 
glycated collagen leading to heavy 
cholesterol deposition which is the first step 
in the pathogenesis of atherosclerosis 
leading to coronary artery disease (19).   
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CONCLUSION 
 
In summary, the findings from our study 
suggest that: 
1. Low density lipoprotein levels are 
elevated in poorly controlled diabetes 
patients. Increased levels of Low-density 
lipoprotein may be a contributory factor to 
the high risk of atherosclerosis observed in 
diabetes patients. 
2. Glycaemic optimization is a good tool to 
improve the components of diabetes 
dyslipidemia. Among the different lipids, 
the elevation of Low-density lipoprotein was 
contributing more for the development of 
coronary artery disease.  
4. Reduction of glycosylated hemoglobin is 
likely to reduce the risk of complication 
mainly coronary artery disease, with the 
lowest risk being in those with glycosylated 
hemoglobin values in the normal range i.e. 
less than 8.0% 
5. However probably not only glycaemic 
optimization but also lifestyle Intervention 
plays a role in the improvement of the 
different components of diabetes 
dyslipidemia. 
6. Diet also has a positive correlation with 
myocardial infraction as patients following a 
mixed diet had significantly higher serum 
cholesterol and Low Density Lipoprotein 
levels than those following a vegetarian diet. 
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